Positron Emission Tomography Market Is Expected To Accumulate A Value Of USD 1463.7 Million by 2030 in Market Research Community

Positron Emission Tomography Market Insights:

Positron emission tomography (PET) Market is a type of medical imaging test that uses specialized cameras and a radioactive tracer to create detailed images of the body's organs and tissues. It is often used to evaluate the function of the heart, brain, and other organs, and can be particularly useful for diagnosing and managing certain types of cancer.

In a recent research report by Market Research Community, the positron emission tomography market is expected to surpass USD 1,463.7 Million by the year 2030, from USD 976.5 Million in 2021

During the predicted term, the cardiology sector is likely to assist the application segment's increased growth. The accurate detection of blood flow to each cardiac muscle, the identification of damaged tissue in the heart, and the efficient diagnosis of coronary artery disorders are all variables.

Get sample Report Here: https://marketresearchcommunity.com/sample-request/?rid=887

European region is expected to be a major contributor to the growth of the positron emission tomography (PET) market in the coming years. There are several factors that are likely to drive this growth, including:

• High disposable income: Many countries in Europe have high levels of disposable income, which can make it more feasible for individuals to access advanced medical technologies such as PET scans.
• Increased awareness of diagnostic interventions: There is a growing awareness of the importance of early diagnosis and treatment for chronic conditions such as cancer, heart failure, and Alzheimer's disease. This is likely to drive demand for PET scans and other diagnostic interventions in the European region.
• Prevalence of chronic diseases: The European region has a large and growing population of older adults, who are more prone to developing chronic conditions. This is likely to increase the demand for PET scans and other diagnostic and therapeutic interventions.

Overall, the combination of these factors is expected to contribute to the growth of the Positron emission tomography (PET) Market Size in the European region in the coming years. The market is projected to grow at a significant pace reaching a CAGR of approximately 4.6%, over the forecast period of 2022–2030, despite a considerable fall in product sales during the initial phase of the pandemic spread and lockdown restrictions imposed globally.

The study is consolidated into major segments and further into sub-segments, such as by product type (partial ring PET scanners, full ring PET scanners), by application (oncology, cardiology, neurology, and other applications), by end-use (hospitals, diagnostic centers, and others), to forecast the market size by value.

By Product Type 

• Full Ring PET Scanners
• Partial Ring PET Scanners

By Application    

• Cardiology
• Neurology
• Oncology

By End-Use

• Hospitals
• Diagnostic centers
• Others       

Lastly, the report includes a regional analysis and country analysis with the latest trends, along with the major key players including Gamma Medica Inc., Oncovision, Koninklijke Philips N.V., Positron Corporation, Siemens AG, Segami Corporation, Naviscan Inc., Spectrum Dynamics Ltd., GE Healthcare, Neusoft Medical Systems, Agfa Healthcare.

Contact:

Market Research Community

Email: [email protected]